US Stock MarketDetailed Quotes

Silence Therapeutics (SLN)

Watchlist
  • 5.850
  • +0.250+4.46%
Close Apr 8 16:00 ET
  • 5.850
  • 0.0000.00%
Post 16:04 ET
276.32MMarket Cap-3.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Silence Therapeutics (SLN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-98.71%559K
-99.87%34K
-89.39%159K
-70.37%224K
-99.10%142K
36.71%43.26M
680.02%25.31M
-56.12%1.5M
-93.42%756K
11.44%15.7M
Operating revenue
-98.71%559K
-99.87%34K
-89.39%159K
-70.37%224K
-99.10%142K
36.71%43.26M
680.02%25.31M
-56.12%1.5M
-93.42%756K
11.44%15.7M
Cost of revenue
-98.18%215K
-99.41%12K
-98.24%64K
-97.45%85K
-98.07%54K
-8.21%11.81M
6.13%2.04M
85.60%3.64M
-6.66%3.33M
-50.14%2.8M
Gross profit
-98.91%344K
-99.91%22K
104.44%95K
105.39%139K
-99.32%88K
67.49%31.45M
1,657.60%23.27M
-247.34%-2.14M
-132.57%-2.58M
52.26%12.9M
Operating expense
-4.93%90.1M
-54.80%12.48M
-5.45%26.34M
9.45%22.78M
54.20%28.5M
13.96%94.77M
28.99%27.62M
64.37%27.86M
-6.94%20.81M
-21.42%18.48M
Selling and administrative expenses
-16.89%22.34M
-32.62%3.73M
-24.71%5.8M
-26.79%5.13M
15.81%7.68M
2.52%26.88M
-8.62%5.54M
27.29%7.7M
8.64%7.01M
-16.94%6.64M
-General and administrative expense
-16.89%22.34M
-32.62%3.73M
-24.71%5.8M
-26.79%5.13M
15.81%7.68M
2.52%26.88M
-8.62%5.54M
27.29%7.7M
8.64%7.01M
-16.94%6.64M
Research and development costs
-0.19%67.75M
-60.37%8.75M
1.91%20.54M
27.86%17.65M
75.71%20.81M
19.22%67.88M
43.86%22.08M
84.94%20.16M
-13.26%13.8M
-23.73%11.85M
Other taxes
----
----
----
----
-7.37%-2.68M
-14.96%-13.74M
----
----
----
---2.5M
Other operating expenses
----
----
----
----
----
-14.96%-13.74M
----
----
----
----
Operating profit
-41.75%-89.75M
-186.33%-12.46M
12.51%-26.24M
3.20%-22.64M
-409.03%-28.41M
1.65%-63.32M
78.33%-4.35M
-93.60%-30M
-61.85%-23.39M
62.91%-5.58M
Net non-operating interest income expense
-22.18%3.48M
148.03%4.47M
1,871.74%12.43M
-510.15%-10.2M
259.94%1.12M
253.88%998.64K
Non-operating interest income
-22.18%3.48M
----
----
----
----
148.03%4.47M
73.18%886.95K
-47.41%1.31M
214.10%1.35M
143.92%1.02M
Non-operating interest expense
----
----
----
----
----
----
----
117,834.03%11.51M
-79.45%231.46K
-98.46%16.41K
Other net income (expense)
-116.19%-2.33M
-122.30%-2.79M
196.16%5.29M
-221.86%-4.71M
-103.44%-121K
54.52%14.38M
12.51M
-5.5M
3.86M
3.51M
Gain on sale of security
-1,410.68%-8.47M
-100.16%-19K
116.97%1.93M
-2,878.83%-6.61M
-1,173.79%-3.77M
124.46%646K
--11.91M
---11.4M
---222K
--351K
Special income (charges)
---1.32M
--0
--0
---1.32M
----
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
--1.32M
--0
--0
--1.32M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
-45.67%7.46M
-566.33%-2.77M
-43.15%3.35M
-20.84%3.23M
15.37%3.65M
14.96%13.74M
--594K
--5.9M
--4.08M
--3.16M
Income before tax
-99.26%-88.6M
-193.22%-11.77M
40.96%-20.96M
-40.03%-27.34M
-1,279.59%-28.53M
16.53%-44.46M
224.41%12.63M
-172.88%-35.5M
-28.91%-19.53M
86.82%-2.07M
Income tax
-98.70%11K
0
-97.96%1K
-95.61%10K
0
-11.61%845K
-96.35%324K
101.67%49K
111.23%228K
107.98%244K
Net income
-95.57%-88.61M
-195.68%-11.77M
41.04%-20.96M
-38.47%-27.35M
-1,134.00%-28.53M
16.45%-45.31M
164.67%12.3M
-253.12%-35.54M
-50.59%-19.76M
81.71%-2.31M
Net income continuous Operations
-95.57%-88.61M
-195.68%-11.77M
41.04%-20.96M
-38.47%-27.35M
-1,134.00%-28.53M
16.45%-45.31M
164.67%12.3M
-253.12%-35.54M
-50.59%-19.76M
81.71%-2.31M
Minority interest income
Net income attributable to the parent company
-95.57%-88.61M
-195.68%-11.77M
41.04%-20.96M
-38.47%-27.35M
-1,134.00%-28.53M
16.45%-45.31M
164.67%12.3M
-253.12%-35.54M
-50.59%-19.76M
81.71%-2.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-95.57%-88.61M
-195.68%-11.77M
41.04%-20.96M
-38.47%-27.35M
-1,134.00%-28.53M
16.45%-45.31M
164.67%12.3M
-253.12%-35.54M
-50.59%-19.76M
81.71%-2.31M
Basic earnings per share
-90.91%-1.89
-200.00%-0.27
40.00%-0.45
-35.71%-0.57
-900.00%-0.6
32.65%-0.99
153.60%0.27
-176.89%-0.75
-15.62%-0.42
83.00%-0.06
Diluted earnings per share
-90.91%-1.89
-200.00%-0.27
40.00%-0.45
-35.71%-0.57
-900.00%-0.6
32.65%-0.99
153.60%0.27
-176.89%-0.75
-15.62%-0.42
83.00%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -98.71%559K-99.87%34K-89.39%159K-70.37%224K-99.10%142K36.71%43.26M680.02%25.31M-56.12%1.5M-93.42%756K11.44%15.7M
Operating revenue -98.71%559K-99.87%34K-89.39%159K-70.37%224K-99.10%142K36.71%43.26M680.02%25.31M-56.12%1.5M-93.42%756K11.44%15.7M
Cost of revenue -98.18%215K-99.41%12K-98.24%64K-97.45%85K-98.07%54K-8.21%11.81M6.13%2.04M85.60%3.64M-6.66%3.33M-50.14%2.8M
Gross profit -98.91%344K-99.91%22K104.44%95K105.39%139K-99.32%88K67.49%31.45M1,657.60%23.27M-247.34%-2.14M-132.57%-2.58M52.26%12.9M
Operating expense -4.93%90.1M-54.80%12.48M-5.45%26.34M9.45%22.78M54.20%28.5M13.96%94.77M28.99%27.62M64.37%27.86M-6.94%20.81M-21.42%18.48M
Selling and administrative expenses -16.89%22.34M-32.62%3.73M-24.71%5.8M-26.79%5.13M15.81%7.68M2.52%26.88M-8.62%5.54M27.29%7.7M8.64%7.01M-16.94%6.64M
-General and administrative expense -16.89%22.34M-32.62%3.73M-24.71%5.8M-26.79%5.13M15.81%7.68M2.52%26.88M-8.62%5.54M27.29%7.7M8.64%7.01M-16.94%6.64M
Research and development costs -0.19%67.75M-60.37%8.75M1.91%20.54M27.86%17.65M75.71%20.81M19.22%67.88M43.86%22.08M84.94%20.16M-13.26%13.8M-23.73%11.85M
Other taxes -----------------7.37%-2.68M-14.96%-13.74M---------------2.5M
Other operating expenses ---------------------14.96%-13.74M----------------
Operating profit -41.75%-89.75M-186.33%-12.46M12.51%-26.24M3.20%-22.64M-409.03%-28.41M1.65%-63.32M78.33%-4.35M-93.60%-30M-61.85%-23.39M62.91%-5.58M
Net non-operating interest income expense -22.18%3.48M148.03%4.47M1,871.74%12.43M-510.15%-10.2M259.94%1.12M253.88%998.64K
Non-operating interest income -22.18%3.48M----------------148.03%4.47M73.18%886.95K-47.41%1.31M214.10%1.35M143.92%1.02M
Non-operating interest expense ----------------------------117,834.03%11.51M-79.45%231.46K-98.46%16.41K
Other net income (expense) -116.19%-2.33M-122.30%-2.79M196.16%5.29M-221.86%-4.71M-103.44%-121K54.52%14.38M12.51M-5.5M3.86M3.51M
Gain on sale of security -1,410.68%-8.47M-100.16%-19K116.97%1.93M-2,878.83%-6.61M-1,173.79%-3.77M124.46%646K--11.91M---11.4M---222K--351K
Special income (charges) ---1.32M--0--0---1.32M------0--0--0--0----
-Less：Restructuring and merger&acquisition --1.32M--0--0--1.32M------0--0--0--0----
Other non- operating income (expenses) -45.67%7.46M-566.33%-2.77M-43.15%3.35M-20.84%3.23M15.37%3.65M14.96%13.74M--594K--5.9M--4.08M--3.16M
Income before tax -99.26%-88.6M-193.22%-11.77M40.96%-20.96M-40.03%-27.34M-1,279.59%-28.53M16.53%-44.46M224.41%12.63M-172.88%-35.5M-28.91%-19.53M86.82%-2.07M
Income tax -98.70%11K0-97.96%1K-95.61%10K0-11.61%845K-96.35%324K101.67%49K111.23%228K107.98%244K
Net income -95.57%-88.61M-195.68%-11.77M41.04%-20.96M-38.47%-27.35M-1,134.00%-28.53M16.45%-45.31M164.67%12.3M-253.12%-35.54M-50.59%-19.76M81.71%-2.31M
Net income continuous Operations -95.57%-88.61M-195.68%-11.77M41.04%-20.96M-38.47%-27.35M-1,134.00%-28.53M16.45%-45.31M164.67%12.3M-253.12%-35.54M-50.59%-19.76M81.71%-2.31M
Minority interest income
Net income attributable to the parent company -95.57%-88.61M-195.68%-11.77M41.04%-20.96M-38.47%-27.35M-1,134.00%-28.53M16.45%-45.31M164.67%12.3M-253.12%-35.54M-50.59%-19.76M81.71%-2.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -95.57%-88.61M-195.68%-11.77M41.04%-20.96M-38.47%-27.35M-1,134.00%-28.53M16.45%-45.31M164.67%12.3M-253.12%-35.54M-50.59%-19.76M81.71%-2.31M
Basic earnings per share -90.91%-1.89-200.00%-0.2740.00%-0.45-35.71%-0.57-900.00%-0.632.65%-0.99153.60%0.27-176.89%-0.75-15.62%-0.4283.00%-0.06
Diluted earnings per share -90.91%-1.89-200.00%-0.2740.00%-0.45-35.71%-0.57-900.00%-0.632.65%-0.99153.60%0.27-176.89%-0.75-15.62%-0.4283.00%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -